Portal de Periódicos da CAPES

An Integrated Multiple-Analyte Pharmacokinetic Model to Characterize Trastuzumab Emtansine (T-DM1) Clearance Pathways and to Evaluate Reduced Pharmacokinetic Sampling in Patients with HER2-Positive Metastatic Breast Cancer

2013; Adis, Springer Healthcare; Volume: 52; Issue: 8 Linguagem: Inglês

10.1007/s40262-013-0060-y

1179-1926

Dan Lu, Amita Joshi, Bei Wang, Steve Olsen, Joo‐Hee Yi, Ian E. Krop, Howard A. Burris, Sandhya Girish,

Cancer Treatment and Pharmacology